Reilly Pidgeon
0000-0002-7372-526X
Publication & Citation Trends
Publications
17 total
The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development
Cited by 36
OpenAlex
Diet-derived urolithin A is produced by a dehydroxylase encoded by human gut Enterocloster species PDF
Cited by 23
OpenAlex
The presence and induction of regioselective dehydroxylases dictate urolithin metabolism by Enterocloster species PDF
Cited by 2
OpenAlex
Abstract 2223: Phase I clinical trial combining camu camu prebiotic enriched with castalagin modulates bile acids and metabolites in combination with cancer immunotherapy in patients with treatment-naïve lung cancer and PD-1 refractory melanoma (NCT05303493)
Cited by 1
OpenAlex
The dietary ellagitannin metabolite urolithin A is produced by a molybdenum-dependent dehydroxylase encoded by prevalent human gut <i>Enterocloster</i> spp PDF
Cited by 2
OpenAlex
Identifying glycan consumers in human gut microbiota samples using metabolic labeling coupled with fluorescence-activated cell sorting PDF
Cited by 23
OpenAlex
Research Topics
Gut microbiota and health
(6)
Ginger and Zingiberaceae research
(5)
Pomegranate: compositions and health benefits
(4)
Phytase and its Applications
(3)
Geological and Geochemical Analysis
(2)
Affiliations
McGill University Health Centre
McGill University
Concordia University